[Hearing impairment in children with cystic fibrosis]
A I Kryukov1, A Yu Ivoilov1, N A Mileshina2
1Sverzhevsky Research Clinical Institute of Otorhinolaryngology, Moscow, Russia.
Insights
Cystic fibrosis patients may experience hearing loss due to aminoglycoside antibiotics. Inflammatory issues also contribute to hearing impairment in children with cystic fibrosis, necessitating further auditory function studies.
Area of Science:
- Pediatric Otolaryngology
- Medical Genetics
- Pharmacology
Background:
- Hearing impairment is a significant concern in children with cystic fibrosis (CF).
- Systemic antibacterial therapy, particularly with aminoglycoside antibiotics, is frequently used in CF management.
- The ototoxic effects of aminoglycosides pose a risk to auditory function in this vulnerable population.
Purpose of the Study:
- To investigate the causes of hearing loss in children with cystic fibrosis.
- To analyze the impact of aminoglycoside antibiotic therapy on auditory function in pediatric CF patients.
- To identify specific risk factors for hearing impairment in this cohort.
Main Methods:
- A comprehensive literature search was conducted.
- Databases utilized included PubMed, Web of Science, and eLibrary.
- The review focused on studies examining hearing function in relation to CF and its treatments.
Main Results:
- Aminoglycoside use is linked to sensorineural hearing loss in CF patients.
- Inflammatory processes in the middle ear and eustachian tube predict conductive hearing loss.
- Aminoglycoside therapy does not universally cause hearing impairment, highlighting individual variability.
Conclusions:
- Further research is crucial to understand the nuances of hearing impairment in children with CF.
- Identifying specific characteristics of hearing loss can inform targeted interventions.
- Monitoring auditory function is essential for children undergoing treatment for cystic fibrosis.
Abstract:
The process of hearing impairment in children suffering from cystic fibrosis remains one of the pressing problems for the scientific medical community today. The article examines the effect of systemic antibacterial therapy with aminoglycoside antibiotics on the auditory function of children with cystic fibrosis.
Objective:
To analyze the causes of hearing loss and the causes of hearing impairment in children with cystic fibrosis from antibacterial therapy with aminoglycoside antibiotics.
Material And Methods:
Search for literature sources using the search engines PubMed, Web of Science and eLibrary.
Results:
A review of the literature shows that the acute problem of sensorineural hearing loss is associated with frequent use of aminoglycosides, and predictors of conductive hearing loss are inflammatory processes in the middle ear and eustachian tube. It has been demonstrated that not in all cases, antibacterial therapy with aminoglycoside antibiotics leads to hearing impairment, which demonstrates the urgent need to study the auditory function of children with cystic fibrosis and identify the characteristics of hearing impairment.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Cystic Fibrosis: Management
Sinus disease and chronic...


